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Background: Whole-genome sequencing is an important tool for understanding microbial evolution and
identifying the emergence of functionally important variants over the course of epidemics. In October 2010, a
severe cholera epidemic began in Haiti, with additional cases identified in the neighboring Dominican Republic. We
used whole-genome approaches to sequence four Vibrio cholerae isolates from Haiti and the Dominican Republic
and three additional V. cholerae isolates to a high depth of coverage (>2000x); four of the seven isolates were
previously sequenced.
Results: Using these sequence data, we examined the effect of depth of coverage and sequencing platform on
genome assembly and identification of sequence variants. We found that 50x coverage is sufficient to construct a
whole-genome assembly and to accurately call most variants from 100 base pair paired-end sequencing reads.
Phylogenetic analysis between the newly sequenced and thirty-three previously sequenced V. cholerae isolates
indicates that the Haitian and Dominican Republic isolates are closest to strains from South Asia. The Haitian and
Dominican Republic isolates form a tight cluster, with only four variants unique to individual isolates. These variants
are located in the CTX region, the SXT region, and the core genome. Of the 126 mutations identified that separate
the Haiti-Dominican Republic cluster from the V. cholerae reference strain (N16961), 73 are non-synonymous
changes, and a number of these changes cluster in specific genes and pathways.
Conclusions: Sequence variant analyses of V. cholerae isolates, including multiple isolates from the Haitian outbreak,
identify coverage-specific and technology-specific effects on variant detection, and provide insight into genomic
change and functional evolution during an epidemic.
Keywords: Whole-genome sequencing, Vibrio cholerae, Haitian cholera epidemic, Microbial evolutionBackground
Following the 2010 earthquake in Haiti, a cholera out-
break began in Haiti’s Artibonite Department and rap-
idly spread across the country. As of March 18, 2012, a
total of 531,683 cholera cases have been reported in
Haiti, with 7056 deaths due to the epidemic (http://
www.mspp.gouv.ht). Cholera cases were also reported in
the Dominican Republic [1,2], and cases linked to the
outbreak strain have been documented in travelers* Correspondence: rsealfon@mit.edu; pardis@broadinstitute.org
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reproduction in any medium, provided the orreturning to their home countries from both Haiti and
the Dominican Republic [1,3].
The absence of a previously recorded history of epidemic
cholera in Haiti [4] raised interest in understanding the
source of this outbreak. In order to further characterize
the Haitian cholera strain, initial studies applied pulsed
field gel electrophoresis and variable number tandem re-
peat typing to a large number of microbial isolates from
the Haitian cholera outbreak [5,6]. These analyses identi-
fied the Haitian cholera strain as V. cholerae O1 El Tor,
placing it as a seventh pandemic strain. In general, these
studies found low levels of genetic variation in isolates,
supporting a point-source origin for the outbreak [5-7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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first introduced into Haiti. Identifying novel microbial
variants that have emerged over the course of the out-
break may provide insight into the organism’s evolution
on a short time scale. Genomic sequencing is the most
powerful approach for evaluating such microbial evolu-
tion. Next-generation sequencing technologies, including
Illumina, PacBio, and 454 sequencing, have increased
the speed and decreased the cost of genome-wide se-
quencing. Chin et al. sequenced two V. cholerae isolates
from Haiti using PacBio sequencing, which produces
longer reads but has a higher error rate than other next-
generation approaches [8]. Reimer et al. used single-end
Illumina-based sequencing to sequence eight V. cholerae
isolates from Haiti and one from the Dominican Republic
[9]. Hendriksen et al. compared Haitian V. cholerae
sequences to sequences from Nepal, finding that the
Haitian isolates are highly similar to a set of isolates
collected in Nepal in the summer of 2010 [10]. These
sequencing studies indicated that the Haitian epidemic
is most closely related to seventh pandemic strains from
South Asia, and that the Dominican Republic outbreak
strain is genetically nearly identical to the Haitian out-
break strain. The recent study of Hasan et al. [11] iden-
tified non-O1/O139 V. cholerae strains in patients in
Haiti, and additional work is needed to explore the po-
tential contribution of such strains to disease in Haiti.
In this study, we used paired-end Illumina sequencing
at a high depth of coverage to sequence one V. cholerae
isolate from the Dominican Republic, three isolates from
Haiti, and three additional V. cholerae isolates. Four of
the isolates were previously sequenced using a variety of
sequencing technologies [8,12,13], and we present a
comparison between sequence data generated using San-
ger-based, next-generation, and PacBio sequencing tech-
nologies. The sequenced isolates include a classical O1-
serogroup isolate from the sixth pandemic and an O139-
serogroup strain as well as O1 El Tor strains from the
seventh pandemic. The diverse strains sequenced and
the high depth of coverage allow us to probe the se-
quence coverage required for optimal assembly and vari-
ant calling of the V. cholerae genome using next
generation sequencing. Our data characterize the depth
of coverage needed to accurately resolve sequence vari-
ation between V. cholerae strains.
We further identify sequence differences between the
Haitian and Dominican Republic isolates in comparison to
previously published and newly sequenced worldwide
samples, and in comparison to each other. The three iso-
lates from Haiti were collected in the same hospital in the
Artibonite Department in October, 2010. The Dominican
Republic isolate was collected three months later, in con-
nection with a cholera outbreak among guests returning
from a wedding in the Dominican Republic [1]. Sinceepidemic cholera had not been reported in Hispaniola
prior to 2010, examining microbial mutations as the out-
break spread from Haiti to the Dominican Republic three
months later provides insight into the temporal evolution
of epidemic V. cholerae.
Results and discussion
Sequencing seven V. cholerae isolates at high depth of
coverage
We sequenced seven V. cholerae isolates, including three
isolates from Haiti (H1*, H2* and H3), one from the
Dominican Republic (DR1), two from Bangladesh
(N16961* and DB_2002), and one from India (O395*).
Four of these isolates (H1*, H2*, N16961*, and O395*)
were previously sequenced using a variety of sequencing
technologies and to varying depths, and are denoted
with an asterisk. We sequenced all strains to high depths
of coverage (2643 – 5631x; Additional file 1: Table S1).
We have deposited the sequence data in the Sequence
Read Archive database (Submission: SRA056415).
Effect of depth of coverage on genome assembly and
single-nucleotide polymorphism (SNP) calling
The high depth of coverage of our sequencing enabled
comparison of the efficacy of de novo assembly and vari-
ant detection at multiple depths of coverage. To assess
the assembly quality, we used the N50 statistic. N50, a
common metric of assembly quality, is the number of
base pairs in the longest contig C such that fewer than
half of the base pairs in the genome lie in contigs that
are longer than C. We selected a random sample of the
total reads for each isolate and compared the median
N50 value for assemblies produced by Velvet at a range
of coverage depths (5x to 250x), with three random read
samples at each depth of coverage. For most isolates,
N50 is stable across the range of depths from 50x to
250x, suggesting that 50x coverage is sufficient to con-
struct a de novo assembly for these samples (Figure 1A).
However, N50 continues to increase up to 100x coverage
in sample H1*. The average read quality in H1* is the
lowest of all the samples (Additional file 2: Figure S2),
suggesting that while 50x is sufficient depth of coverage
for de novo genome assembly on most samples, greater
coverage is needed when average base quality is low.
We explored the effect of depth of coverage on calling
sequence variants by examining the SNPs, insertions,
and deletions identified at a range of coverage depths
(5x to 250x). For all isolates, the number of SNPs identi-
fied increases sharply up to 50x coverage, and continues
to increase gradually after this point (Figure 1B). In six
of the seven isolates, at least 85% of the SNPs identified
at 250x coverage are also identified at 50x coverage (the
exception was the O395 sample, since at 50x coverage,
we did not detect one of the three SNPs found at 250x












































Figure 1 Fiftyfold coverage suffices for whole-genome
assembly and detection of most sequence varients. (A) The N50
of the assembly, shown over a range of coverage depths (5x-250x),
rapidly increases up to 50x coverage, and then plateaus. The median
N50 of assemblies of five disjoint sets of reads at each depth of
coverage is shown. (B) The number of SNPs detected increases
rapidly up to 50x coverage, and gradually thereafter. (C) The number
of insertions and deletions detected increases rapidly up to 20x
coverage, and plateaus after 50x coverage. SNPs, insertions, and
deletions in all isolates except for O395* are called relative to the
N16961 genome [GenBank:AE003852, GenBank:AE003853]. For the
O395* sample, due to the large number of differences (>20,000
SNPs) from the N16961 reference, SNPs, insertions, and deletions
were identified instead against the Sanger-sequenced O395
reference [GenBank:CP000626, GenBank:CP000627].
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coverage include variants in regions where the average
base quality is low, regions with unusually low depths of
coverage compared to the rest of the genome, and
regions with false positive calls due to misalignment of
reads across a deletion. Fifty-fold coverage is also suffi-
cient to identify nearly all of the insertions and deletions
observed at higher depths of coverage (Figure 1C). At
50x coverage, we detected at least 98% of the insertions
and deletions observed at 250x coverage in each isolate.
Twenty-fold coverage is sufficient to detect the majority
of insertions and deletions; at least 90% of insertions and
deletions that are observed at 250x coverage are also
found at 20x coverage in five of the seven isolates. These
results suggest that 50x coverage is sufficient to accur-
ately call most variants, although deeper coverage pro-
vides additional power for identifying SNPs in some
genomic regions.
Comparison of sequence variants, insertions, and
deletions identified using multiple sequencing
approaches
Four of our isolates were previously sequenced using a
variety of platforms. Those sequencing results provide
an opportunity for us to compare variant calls across se-
quencing technologies, validate variant calls, and identify
potential errors in reference sequences.
Comparison to N16961 Sanger reference sequences
The original reference genome for V. cholerae was the
Sanger-sequenced N16961 genome [12]. Feng et al. sub-
sequently identified a number of corrections to the refer-
ence based on comparisons to additional strains at
ambiguous positions and open reading frame clone se-
quence data [13]. Their corrections included 58 single
base pair differences and 63 insertions and deletions.
Similarly, we identified 59 single base pair differences as
well as 95 insertions and deletions between N16961*
and the N16961 reference [12] (Figure 2B).
To validate variant calls where the N16961* sequence
differs from the corresponding reference, we examined
the positions corresponding to those differences, using
the Microbial Genome Browser alignment. Positions that
differ between the reference sequence and the new iso-
lates may represent errors in the reference sequence,
false positive SNP calls, or mutations introduced during
lab passage of the strains. If the discrepancy is due to an
error in the reference sequence, then the sequences of
additional strains in the alignment (O395 and MO10 for
the N16961 sequence, N16961 and MO10 for the O395
sequence) are likely to agree with our variant call and
disagree with the reference (Additional file 3: Figure S3).
For 54 of the 59 differences, the alignments to strains
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Figure 2 Comparison of SNPs, insertions, and deletions called across sequencing technologies. (A) List of published sequences for the
four previously sequenced isolates (N16961, O395, H1, and H2) examined in this study. (B) Comparison of new Illumina sequences to GenBank
references. The number of differences identified in the new sequence relative to the GenBank reference is shown in the table, with the number
of differences confirmed by alignment to additional strains shown in parentheses. (C) Comparison of Illumina-based and PacBio-based SNP,
insertion, and deletion calls relative to the Sanger-sequenced N16961 reference [GenBank:AE003852, GenBank:AE003853]. The number of variants
called in PacBio sequencing only (red circle), in Illumina sequencing only (blue circle), or in both (intersection) are shown. For the N16961
sequences, the number of differences confirmed by alignment to additional strains is shown in parentheses. For H1 and H2, only variants that do
not correspond to likely errors in the N16961 reference sequence are counted.
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itional strains supports all but one of the 95 insertions
and deletions identified between N16961 and N16961*,
consistent with the interpretation that the discordant
positions correspond to errors in the reference sequence.
We combined the corrections to the N16961 reference
sequence previously identified by Feng et al. [13] with
the validated variants that we identified to generate an
updated list of sequence corrections (Additional file 4:
Table S4).
Comparison to O395 Sanger and O395 ABI/454 sequences
To identify positions at which the sequence differed
across multiple technologies, we compared the O395*
sequence to the O395 Sanger and ABI/454-sequenced
references ([GenBank:CP000626, GenBank:CP000627]
and [GenBank:CP001235, GenBank:CP001236], respect-
ively). We detected 3 SNPs between the O395* isolate
and the Sanger-sequenced reference. BLAST queries
indicated that in closely related strains, the sequence
matches the reference at the position of these SNPs.
However, manual examination of the SNP positions indi-
cated that they are likely to be real variants, suggesting
that they may have been introduced during laboratory
passage of the O395 isolate (Additional file 5: Figure S5).
We did not detect any insertions or deletions between
the O395* sample and the O395 Sanger-sequenced refer-
ence. Between the O395* sequence and the ABI/454-
sequenced O395 reference (Figure 2B), we detectedseven additional single-base pair differences, four dele-
tions, and one insertion. The accuracy of our Illumina
calls at nine of these twelve positions is supported by
their agreement with the Sanger-sequenced reference;
for the other three positions, the Sanger-sequenced
reference agrees with the ABI/454 calls.
Comparison to PacBio sequences
We compared three of the isolates that we sequenced
(N16961*, H1*, and H2*) to previously published PacBio
sequences for these same isolates (Figure 2C) [8]. In the
N16961* sample, 83% of the SNPs that we identified
(49/59 differences) were also present in the PacBio-
based SNP calls. We identified ten SNPs not found in
the PacBio variant calls, seven of which are validated by
alignment to additional strains. Chin et al. reported five
SNPs that we did not detect. Four of the five variants
identified uniquely in the PacBio-based calls lie in repeti-
tive regions of the genome, and these calls are supported
by alignment to additional strains. The remaining SNP is
not supported by alignment to additional strains. Al-
though the majority of single nucleotide variant calls
were consistent across platforms, only 55% of our
Illumina-based insertions and deletions were also found
using PacBio sequencing (52/95 indels). We identified
43 insertions and deletions in the N16961* sample not
identified in the PacBio sequencing, and Chin et al.
reported seven insertions and deletions that we did not
recover. Only one of the seven insertions and deletions
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ment to additional strains, suggesting that the Illumina-
based sequencing of the N16961 strain provided more
sensitive and specific detection of insertions and dele-
tions than the PacBio-based sequencing.
We also compared the variants identified in the H1
and H2 isolates relative to the N16961 reference by Pac-
Bio sequencing (H1, H2) with those identified by Illu-
mina sequencing (H1*, H2*) (Figure 2C). Ninety-five
percent (121/128) of the SNPs we identified in H1* were
identified in the PacBio sequencing as well, while 83%
(111/133) of the SNPs we called in H2* were also called
in the PacBio sequencing. Thirty-one SNPs were identi-
fied uniquely in the PacBio sequencing of H1, while 28
SNPs were identified uniquely in the PacBio sequencing
of H2. Many of the variant calls (11 in H1, 12 in H2)
that were identified only by PacBio sequencing lie in re-
peat regions of the genome, suggesting that the long
PacBio reads may facilitate detection of SNPs in repeti-
tive regions of the genome that are difficult to recover















































































































RC385 (Chesapeake Bay, 1998)
Figure 3 Phylogeny of the sequenced strains and 33 previously sequ
phylogeny using RaxML based on genes conserved across all newly seque
The isolates sequenced in our study are shown in red.deletions that we identified in H1* and H2*, only 20-30%
(3/9 for H1, 2/10 for H2) were also recovered in the
PacBio-based calls. The PacBio-based sequencing identi-
fied 16 insertions and deletions in H1 and 18 in H2 not
found in the Illumina-based calls. Thus, while both the
Illumina-based and the PacBio-based sequencing identi-
fied similar SNPs, the insertion and deletion calls were
highly divergent between the two approaches.
Identifying SNPs, insertions, deletions, and structural
variation across isolates
Analysis of an O139 serogroup isolate from Bangladesh
The O139 serogroup isolate from Bangladesh (DB_2002)
was collected in Dhaka in 2002 and has not been previ-
ously sequenced. Relative to the N16961 reference strain,
the isolate has deletions in the VPI-II genomic island,
the superintegron, and a region on chromosome 1 asso-
ciated with O antigen synthesis which contains genes
involved in lipopolysaccharide and sugar synthesis/modi-
fication. The DB_2002 isolate contains two long regions










































































































enced V. cholerae isolates. We constructed a maximum-likelihood













































Figure 4 Variation in depth of coverage of the sequenced
isolates, based on read alignments of the seven sequenced
strains against the N16961 reference genome. Chromosome 1
(A) and chromosome 2 (B) are shown. The depth of coverage of
1000 base pair windows of 150x average coverage subsamples of
the DR1 (outermost circle), H1*, H2*, H3, N16961*, O395*, and
DB_2002 (innermost circle) isolates is displayed. Regions at low
depth of coverage (<12x) are shown in red, while regions at high
depth of coverage (>240x) are shown in blue. The depth of
coverage in each window is displayed using the Circos tool [34].
Genomic islands as defined in [15] and the superintegron region as
defined in [8] are shown.
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region in an O139-serogroup strain from southern India
that encodes genes for O-antigen synthesis [GenBank:
AB012956.1]. The DB_2002 assembly also contains an
84,000-base pair region matching SXT integrative and
conjugative element sequences in GenBank.
The genomic content of the DB_2002 isolate is similar
to that of other O139 serogroup isolates. Phylogenetic
analysis indicates that DB_2002 clusters closely with an
O139 serogroup isolate from India (MO10, [GenBank:
AAKF03000000]) (Figure 3). The deletions in the superin-
tegron, absence of the VPI-2 genomic island, presence of
the SXT region, and differences in O antigen genes are
characteristic of other O139-serogroup isolates [14,15].
Analysis of Dominican Republic and Haitian isolates
The Haitian and Dominican Republic isolates cluster
closely together and group in the phylogenetic tree with
other seventh pandemic strains (Figure 3). Among the
isolates in our phylogeny, the Haitian and Dominican
Republic strains cluster most closely with strains from
Bangladesh (CIRS101, [GenBank: ACVW00000000] and
MJ-1236, [GenBank:CP001485, GenBank:CP001486]). In
the alignments used to construct the phylogeny, there
are an average of 12 substitutions between the newly
sequenced Haitian/Dominican Republic isolates and
CIRS101, and an average of 46 substitutions between the
Haitian/Dominican Republic isolates and MJ-1236.
To further characterize the Haitian and Dominican
Republic isolates, we identified deletions and copy num-
ber variation relative to reference sequences (Figure 4).
In all Haitian and Dominican Republic isolates, deletions
were observed in the VSP-2 and superintegron regions.
There are also deletions in the SXT region of the Haitian
and Dominican Republic isolates relative to the MJ-1236
reference strain from Bangladesh (Additional file 6:
Figure S6). To identify novel insertions, we aligned a
150x-coverage sample of N16961* reads to the de novo
assembly of each Dominican Republic and Haitian iso-
late. All 1000-base pair windows in the de novo assem-
blies of the Haitian and Dominican Republic isolates to
which N16961* reads did not map matched SXT inte-
grating conjugative element sequences in GenBank, sug-
gesting that no additional large insertions are present in
the genomes of these isolates.
The four isolates from Haiti and the Dominican
Republic are nearly identical in genomic sequence, con-
sistent with a clonal origin for the epidemic. We identi-
fied three SNPs between the Haitian and Dominican
Republic isolates, as well as one additional mutation in
one of the Haitian isolates (Table 1). No sequence differ-
ences were identified between isolates H1* and H3, and
no large-scale structural variation was observed across
the Haitian and Dominican Republic isolates.Functional annotation of variants in Haitian and Dominican
Republic cholera strains
The four isolates from Haiti and the Dominican Republic
(DR1, H1*, H2*, and H3) are nearly identical in genomic
sequence and share 126 variants relative to the N16961
Table 1 Unique single nucleotide polymorphisms identified in individual Haitian and Dominican Republic cholera
strains, in comparison to all other Haitian and Dominican Republic strains
Isolate Chromosome Location Ref Allele Variant Allele Associated gene Type of change
DR1 1 1565917/1572833* T C rstA Upstream of gene
H2* 2 166022 C T TagA-related protein Nonsyn
DR1 2 467913 G A Pyruvate-flavodoxin oxidoreductase Syn
DR1 1 3055641† A C Transposase Tn3 family protein Nonsyn
*The two locations provided for the rstA-related mutation correspond to the two copies of this gene in the N16961 reference strain.
†While all other genomic coordinates in the table are specified with respect to the N16961 reference strain, this variant lies in the SXT region, absent from the
N16961 reference. Here, the genomic coordinates are specified with respect to the MJ-1236 reference.
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synonymous mutations in coding genes (Additional file 7:
Table S7). Notably, a number of the non-synonymous
mutations occur in the same gene, or in genes with similar
function, potentially indicating adaptive convergence. These
include three mutations in the cholera enterotoxin (B sub-
unit), and two mutations in MSHA biogenesis proteins
(MshJ and MshE), which are involved in bacterial adhesion
[16]. There are also two mutations that lie in two distinct
DNA mismatch repair proteins, and two mutations in two
outer membrane proteins, OmpV and OmpH.
In order to identify purifying or positive selection be-
tween the N16961 reference and the Haitian/Dominican
Republic V. cholerae strains, we simulated random
mutations in the cholera genome. To simulate random
point mutations, we selected a genomic position uni-
formly at random, looked up the nucleotide at that pos-
ition, and then randomly selected one of the three other
possible bases at that position. We set the number of
mutations equal to the number of differences between
the N16961 reference and the Haitian/Dominican
strains, and repeated the simulation 1000 times. At each
iteration, we identified changes encoding non-
synonymous substitutions (encoding a different amino
acid than the original base, or a stop codon). When sub-
stitutions between each pair of nucleotides occurred
with equal probability, synonymous changes were over-
represented in the Haitian/Dominican Republic strains
relative to the simulated data (p < 0.01), suggesting puri-
fying selection. However, with transitions twice as likely
as transversions, the enrichment of synonymous changes
in the actual sequences relative to the simulation was
not significant (p = 0.1).
We identified four mutations that occurred within the
Haitian and Dominican Republic isolates (Table 1;
Additional file 8: Figure S8), one in the SXT region, one
in the CTX region, and two in the core genome. Three
point mutations separated the Dominican Republic iso-
late from the Haitian isolates. These include a synonym-
ous change in the pyruvate-flavodoxin oxidoreductase
gene and a nonsynonymous substitution in transposase
in the SXT region of the genome; both were also identi-
fied by Reimer et al. [9]. The third mutation separatingthe Dominican Republic and Haitian isolates is either
within (according to [17]) or upstream (according to
[GenBank:AE003852.1]) of the rstA gene, in the CTX re-
gion of the genome. The mutation upstream of rstA is in
a region identified as bound by RstR in a DNAse I pro-
tection assay [17]. We also identified a non-synonymous
mutation unique to one of the Haitian isolates in the
tagA-related gene.
Conclusions
The three Haitian isolates, the Dominican Republic iso-
late, and the other isolates that we have sequenced pro-
vide insight into the changes in V. cholerae over the
course of the recent epidemic in Hispaniola. We identi-
fied four unique SNPs in individual Haitian and
Dominican Republic cholera strains, in comparison to
all other Haitian and Dominican Republic strains. One
of these mutations is in the SXT region, one is in the
CTX region, and two are in the core genome. These
mutations include three mutations between the Haitian
and Dominican Republic isolates, as well as one muta-
tion unique to a single Haitian isolate. Our observation
of three SNPs between isolates that are separated by
three months is consistent with a recent estimate of an
accumulation rate of 3.3 SNPs/year in the core V. cho-
lerae genome [18].
The Haitian epidemic illustrates the transmission of V.
cholerae across geographical boundaries. Multiple stud-
ies [8-10,19] have suggested that the Haitian cholera
outbreak strain is likely to have originated in South Asia,
and our analysis supports this conclusion. Clinical cases
linked to the Haitian cholera strain have occurred in the
Dominican Republic and in travelers who have recently
visited the region. Thus, the use of whole-genome se-
quencing to trace the evolution of a strain involved in an
ongoing outbreak is clinically relevant both for under-
standing an existing epidemic and for tracking related
cases occurring in other regions.
Whole-genome sequencing of disease-causing organ-
isms can reveal genetic differences between isolates that
may be driven by adaption to new host or environmental
factors. One of the mutations we identified between the
Dominican Republic and Haitian isolates is in a region
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RstR [17], suggesting that this mutation might affect
regulation of gene expression. This mutation is located
upstream of the rstA gene, which is necessary for repli-
cation of the CTX phage genome [20]. The mutation in
the Haitian isolate H2* is located in TagA-related pro-
tein. TagA-related protein is secreted extracellularly by
V. cholerae [21] and is a homolog of TagA, which has
mucinase function [22]. Sequencing of additional isolates
from this outbreak over time is likely to provide further
clues on the evolutionary dynamics of the V. cholerae
genome.
Since even a single base pair mutation may have func-
tional significance, accurate and complete detection of
sequence variation is important. Understanding the ef-
fect of technical variables such as sequencing platform
and depth of coverage is key to identifying genomic
changes over the course of an epidemic. By sequencing
to a high depth of coverage and re-sequencing strains
that were previously sequenced using a variety of tech-
nologies, we were able to compare variant detection
across multiple sequencing platforms and depths of
coverage. We found that 50-fold coverage is sufficient
for genome assembly and for the detection of most se-
quence variants, although some additional variants are
detected at higher coverage depths. The majority of vari-
ant calls, insertions, and deletions are identified across
the isolates regardless of sequencing technology. How-
ever, we also identified a set of sequence variants, inser-
tions, and deletions that were observed uniquely in each
platform. The high depth of coverage and low error rate
of our Illumina sequencing permits accurate detection of
sequence variants, insertions, and deletions. The long
reads produced by the PacBio technology allows the
identification of some additional variants, particularly in
repeat regions. As increasing quantities of sequence data
become available and new sequencing technologies
emerge, further work will be needed to identify the
effects of sequencing platform and analysis pipeline on
the genome-wide identification of variants.
The increasing speed and decreasing cost of whole-
genome sequencing permits the rapid characterizationTable 2 Vibrio cholerae Isolates sequenced
Sample Origin Date V. c
DR1 Dominican Republic January 2011 O1 E
H1* Artibonite Province, Haiti October 2010 O1 E
H2* Artibonite Province, Haiti October 2010 O1 E
H3 Artibonite Province, Haiti October 2010 O1 E
N16961* Bangladesh 1971 O1 E
O395* India 1965 O1 c
DB_2002 Bangladesh 2002 O13
An asterisk (*) denotes samples that have been previously sequenced.of microbial isolates over the course of an epidemic.
Whole-genome sequencing can be used to track gen-
omic evolution and functional variation in real time, to
identify patterns of disease spread within a region, and
to identify the source of an epidemic by tracing relation-
ships to other strains around the world. Whole-genome
sequencing is a powerful epidemiological tool whose
applications towards understanding infectious disease
are only beginning to be explored.
Methods
V. cholerae samples
We sequenced seven V. cholerae isolates. These samples
include three clinical isolates from the cholera outbreak
in Haiti isolated in October 2010, one clinical isolate
from a cholera patient returning to the U.S. from the
Dominican Republic isolated in January 2011, the V. cho-
lerae O1 El Tor reference strain N16961 (Bangladesh,
1971 outbreak), the V. cholerae O1 classical reference
strain O395 (India, 1965), and a 2002V. cholerae O139
clinical isolate from Bangladesh (Table 2). The three
Haitian isolates were all collected within days of each
other in a single hospital in the Artibonite Department.
Four of the seven samples have been previously
sequenced using different sequencing technologies, and
we denote these samples with an asterisk (*). Thus, we
denote the samples from Haiti as H1*, H2*, and H3; the
sample from the Dominican Republic as DR1; the sam-
ples from Bangladesh as N16961* and DB_2002; and the
O1 classical reference strain from India as O395*.
Sample preparation/isolation
We obtained clinical isolates (H1, H2, H3, DR1,
DB_2002) from spontaneously passed human stool sam-
ples of patients with a diagnosis of cholera. All patients
received standard medical treatment for cholera, appro-
priate to their medical condition. Bacteria were recov-
ered from discarded stool specimens; no patient
identifiers were collected and this was judged to be re-
search exempt from human studies approvals by the ap-
propriate Institutional Review Boards. Bacterial isolates
were shipped from Haiti (H1, H2 and H3) andholerae serogroup and biotype Previous sequencing method
l Tor
l Tor PacBio [8]
l Tor PacBio [8]
l Tor
l Tor Sanger [12], PacBio [8]
lassical Sanger (GSCID), ABI/454 [13]
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of appropriate licenses. DR1 is a clinical isolate from a
cholera patient returning to the U.S. from the Domin-
ican Republic. Isolates were confirmed as V. cholerae by
standard biochemical assays and standard immunoagglu-
tination assays. N16961 and O395 are common labora-
tory stock isolates (corresponding to ATCC 39315 and
39541 respectively) that have been maintained in gly-
cerol at −80 degrees C.
Illumina-based whole genome sequencing
We extracted DNA from V. cholerae strains using
QiagenDNEasy (Qiagen, Valencia, CA). For Haitian
strain H1* and Dominican Republic strain DR1, we frag-
mented samples by nebulization at 55 psi for four min-
utes. To isolate a 200 bp band, we ran the fragmented
DNA on the Pippin Prep gel system (Sage Science,
Beverly, MA). We processed samples H1* and DR1
using the commercial genomic DNA library preparation
protocol (Illumina, San Diego, CA). Briefly, we end-
repaired, 3’- adenylated, and adapter-ligated DNA frag-
ments using standard Illumina adapters. We selected li-
braries by size and enriched by PCR for 15 cycles.
We received the remaining V. cholerae isolates
(Table 2) at a later date and fragmented DNA from these
isolates to approximately 200 bp using a Covaris shear-
ing instrument. We prepared the fragmented DNA for
sequencing using the commercial Illumina protocol for
TruSeq DNA library preparations (Illumina, San Diego,
CA). We selected libraries by size and enriched by PCR
for 15 cycles to maintain consistency between methods.
We clustered the resulting libraries for all isolates in
individual flow cell lanes and sequenced for 100 cycles
on an Illumina HiSeq Analyzer, using paired-end tech-
nology. We filtered sequence reads based on quality
scores. The resulting reads had high depth of coverage
(> 2000x for each isolate when mapped to the N16961
reference genome using MAQ, a short read alignment
tool [23]), enabling de novo assembly.
De novo assembly
Using the Velvet genome assembler (v. 1.0.19) [24], we
assembled the genomes on a subsample of reads from
each isolate (69x-176x coverage when mapped using
MAQ to the N16961 reference genome). We used the
VelvetOptimiser script (version 2.1.17) to optimize the
assembly parameters. We assessed the performance of
the assembler on sets of reads at varying depths of
coverage (Figure 1A).
Comparison of sequence variants across sequencing
technologies
We aligned subsamples of N16961* and O395* reads
(150x coverage) to the corresponding published fullgenomes (Sanger-sequenced N16961 and Sanger-
sequenced O395; Heidelberg et al., 2001, GSCID). We
identified SNPs, insertions, and deletions as described
above (Additional file 9: Table S9). We also compared
the PacBio-based variant calls for isolates H1, H2, and
N16961 [8] to variant calls for H1*, H2*, and N16961*
(Figure 2A). To validate differences between the
N16961* sequence and the N16961 published reference,
we examined the alignment to additional strains using
the Microbial Genome Browser [25]. Since the Microbial
Genome Browser alignment track was not available for
the O395 sequence, we used BLAST to examine the cor-
responding bases in related strains for positions at which
the O395* sequence differed from the Sanger-sequenced
O395 reference.
Identifying SNPs, insertions, deletions, and structural
variation across isolates
We called SNPs, insertions, and deletions on three non-
overlapping 150x subsamples of reads. SNPs, insertions,
and deletions shared among all three subsamples are
reported here (Additional file 10: Table S10). Using the
BWA short-read aligner [26], we aligned each 150x read
subsample to the N16961 reference genome [GenBank:
AE003852, GenBank:AE003853]. For the O395* sample,
we aligned instead against the Sanger-sequenced O395
reference [GenBank:CP000626, GenBank:CP000627].
We recalibrated base quality scores and performed re-
alignment around insertions and deletions using the
Genome Analysis Toolkit, a framework for analyzing
next-generation sequence data [27]. We called SNPs
using the variant detection tool Varscan [28], requiring a
minimum SNP frequency of 25% to allow for SNP call-
ing in repeat regions of the genome. To reduce sequen-
cing artifacts, we required that the variant call be
represented on reads in both directions, with no more
than three-quarters of the variant calls on reads in the
same direction when fewer than 90% of the reads carried
the variant call.
We identified small insertions and deletions on the
realigned, recalibrated pileup files (aligned to the
N16961 reference genome) using Varscan, requiring a
75% variant frequency. To restrict the variant set to dif-
ferences with the reference genome, we removed var-
iants identified between the N16961* isolate and the
N16961 reference. For functional annotation of SNPs,
we used the snpEff software [29].
To identify large-scale structural variants, we exam-
ined variation in the depth of coverage in 1000-base pair
windows when a sub-sample of the reads was aligned
against the N16961 and MJ-1236 [30] reference gen-
omes, similar to the approach in Chin et al. [8]. To iden-
tify large insertions relative to the N16961* genome, we
used MAQ to align a 150x-coverage subsample of the
Sealfon et al. BMC Genomics 2012, 13:468 Page 10 of 11
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We characterized all thousand base pair windows with-
out aligned reads using a BLASTn search against the
“nr/nt” database.
In order to identify high-confidence sequence differ-
ences across the Haitian and Dominican Republic iso-
lates, we used Fisher’s exact test based on counts of
reads aligned at each position to the N16961 and MJ-
1236 reference genomes, similar to the approach imple-
mented in the Nesoni tool [31]. We eliminated reads
with quality scores with a greater than 1% estimated
error rate from the count, as well as positions at which
more than three-quarters of variant calls were on reads
in the same direction. We removed variant calls based
on sequence reads with multiple differences from the
reference as well as at positions where more than a
quarter of the reads in both isolates carried the variant
call. We reported high-confidence SNPs with
Bonferroni-corrected p < 0.01.Constructing a phylogeny
To construct a phylogeny, we identified genes conserved
across all newly sequenced isolates as well as 33 previ-
ously sequenced V. cholerae isolates (Additional file 11:
Table S11). We included all genes for which the top
BLAST hit to the N16961 reference gene had at least
70% identity in all strains. To eliminate paralogs, we
required the next best hit to be less than 0.8 times as
similar as the best hit. We constructed a multiple se-
quence alignment for the nucleotide sequences of the
1740 genes meeting these criteria using the multiple se-
quence alignment tool MUSCLE [32]. We concatenated
the alignments of genes present in all strains, and con-
structed a maximum-likelihood phylogeny with RaxML
[33], using the General Time Reversible model of nu-
cleotide substitution.Additional files
Additional file 1: Table S1. Depth of coverage and number of reads
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